A newly approved drug for type 2 diabetes and kidney disease, sotagliflozin, has shown remarkable benefits in reducing the ...

Valentine’s Day has come and gone, but it’s never too late to focus on your heart health.  A groundbreaking new study ...

“Including soluble fiber at breakfast is one of the most effective ways to lower LDL cholesterol,” says Veronica Rouse, RD, ...

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

February is American Heart Month — a time dedicated to raising awareness about heart disease, the leading cause of death in the country. While many understand the general risk factors, ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Related: These Anti-Inflammatory Foods May Reduce COVID-19 Risk and Severity, According to New Study For those who haven’t ...

Judith Yurcho and Dr. Edward Polashenski were recently honored as the 2024 Patients of the Year by the cardiac rehabilitation staff at the Health & Wellness Center at Hazleton. The cardiac ...

From menopause to stress, here is everything Black women need to know about living with and preventing heart disease.

Cardiovascular diseases claim more lives in the U.S. than all forms of cancer and accidental deaths combined, according to ...

This month’s Bon Secours’ Health Matters segment focuses on the impacts of heart disease on women – and how the impacts are different than in men.